Long-Term Assets: The sum of all assets classified as non-current.
Royalty Pharma PLC (RPRX) had Long-Term Assets of $18.09B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.38B |
|
$770.95M |
|
-- |
|
$2.38B |
|
$818.67M |
|
$1.56B |
|
$-235.33M |
|
$1.32B |
|
$1.28B |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
$1.28B |
|
$1.56B |
|
$1.59B |
|
429.80M |
|
564.46M |
|
$1.79 |
|
$1.78 |
|
| Balance Sheet Financials | |
$1.53B |
|
$16.21B |
|
|
Long-Term Assets |
$18.09B |
$19.62B |
|
$636.21M |
|
$8.57B |
|
$9.27B |
|
$9.91B |
|
$9.71B |
|
$8.79B |
|
$9.71B |
|
988.63M |
|
| Cash Flow Statement Financials | |
$2.49B |
|
$-1.61B |
|
$-1.19B |
|
$929.03M |
|
$618.70M |
|
$-310.33M |
|
$289.89M |
|
$-900.63M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
0.47 |
|
0.92 |
|
100.00% |
|
65.58% |
|
65.58% |
|
66.94% |
|
55.68% |
|
32.42% |
|
$2.49B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
81.12 |
|
4.50 |
|
13.63% |
|
15.06% |
|
6.75% |
|
7.24% |
|
$9.83 |
|
$4.41 |
|
$4.41 |
|